Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic

NCT04404244 is registered in ClinicalTrials.gov with Fatma Soliman Elsayed Ebeid, MD as lead sponsor.

NCT NCT04404244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04404244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic
Lead sponsor
Fatma Soliman Elsayed Ebeid, MD
Phase
Observational
Overall status
Completed
Start date
January 1, 2020
Completion date
January 1, 2024
Enrollment
800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus covid-19